Gerd Kochendoerfer - 30 Jan 2026 Form 4 Insider Report for AtaiBeckley Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Feb 2026, 18:54:03 UTC
Prior SEC filing
03 Jan 2025
Next SEC filing
29 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ryan Barrett, as attorney in fact

Key filing fact

Gerd Kochendoerfer filed Form 4 for AtaiBeckley Inc. on 03 Feb 2026.

Key facts

  • This page summarizes Gerd Kochendoerfer's Form 4 filing for AtaiBeckley Inc..
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 03 Feb 2026, 18:54.

Change

  • Previous filing in this sequence was filed on 03 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002047433 Primary reporting owner

Kochendoerfer Gerd

Relationship
Chief Operating Officer
Address
C/O ATAI LIFE SCIENCES US, INC., C/O INDUSTRIOUS NYC, 250 WEST 34TH ST., NEW YORK
Signature
/s/ Ryan Barrett, as attorney in fact
Signature date
03 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

No ticker transaction Derivative

Stock Option

Award

Transaction value
$0
Shares
+675,000
Change %
Price
$0.000000
Shares after
675,000
Date
30 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
675,000
Exercise price
$3.76
Footnotes
F1
No ticker transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+150,000
Change %
Price
$0.000000
Shares after
150,000
Date
30 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,000
Exercise price
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The stock option vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying the option on January 1, 2027 and as to the remaining 75% of the total number of shares in 36 substantially equal monthly installments thereafter.

Footnote F2

Each restricted stock unit vests (subject to continued service through each such vesting date) as to 25% of the total number of shares underlying such award on January 1, 2027 and as to the remaining 75% of the total number of shares on each of the first three anniversaries of January 1, 2027.

SEC remarks

Exhibit 24 - Power of Attorney.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .